5//SEC Filing
Protea Biosciences Group, Inc. 5
Accession 0001144204-14-008860
CIK 0001335103operating
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 9:53 PM ET
Size
9.9 KB
Accession
0001144204-14-008860
Insider Transaction Report
Form 5
POWELL MATTHEW
Dir. R&D; Chief Science Off.
Transactions
- Award
Stock Option
2005-12-15$40000.00/sh+80,000$3,200,000,000→ 80,000 totalExercise: $0.50From: 2005-12-15Exp: 2015-12-15→ Common Stock (80,000 underlying) - Award
Stock Option
2007-01-19$125000.00/sh+100,000$12,500,000,000→ 180,000 totalExercise: $1.25From: 2007-01-19Exp: 2017-01-19→ Common Stock (100,000 underlying) - Award
Stock Option
2009-12-31$60000.00/sh+40,000$2,400,000,000→ 220,000 totalExercise: $1.50From: 2009-12-31Exp: 2019-12-31→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]Represents shares vested as of February 10, 2014.
Documents
Issuer
Protea Biosciences Group, Inc.
CIK 0001335103
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001335103
Filing Metadata
- Form type
- 5
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 9:53 PM ET
- Size
- 9.9 KB